Starwood Hotels & Resorts said hackers stole customer credit-card and debit card information during a data breach that lasted nearly eight months and affected 54 locations, including a number of luxury properties. The breach was... read more...
Happy Thanksgiving from Oxford Risk Management Group!
May this Thanksgiving be a bountiful one in feast, friends, family and fun... read more
U.S. Auto Regulator Hits Takata with $70 Million Fine in Air-Bag Settlement
The Japanese air-bag manufacturer, Takata, agreed to the penalty for failing to alert the regulators in a timely manner to a timely defect in some air-bag inflaters that can cause them to explode and spray... read more...
The Coming Government Takeover of Drug Pricing
The coming government takeover of drug pricing comes on the heels of the democratic led effort in congress to demonize drug-company profits and pushes the federal control over how drugs are priced. The Coming Government... read more
Oxford Offices Closed November 26th & 27th, 2015
The Oxford offices will be closed Thursday, November 26th and Friday, November 27th in observance of the Thanksgiving holiday. We will reopen on Monday, November 30, 2015 at 8:00am EST. Have a safe and relaxing... read more
70,000 Ways to Classify Ailments
Doctors, hospitals and insurers are braced for a possible interruption after the U.S> healthcare system switched to a massive new set of codes for describing illnesses and injuries. Under the new system, health care providers... read more
Railroads Lose Challenge of Oil-Train Rules
Railroads lost an agency appeal with the U.S. Department of Transportation in a battle over new crude-by-rail rules that require the installation of expensive new brakes on trains hauling hazardous flammable materials. The Association of... read more...
Generic Nexium Pill Blocked in the U.S. Over the Purple Color
AstraZeneca has spent billions over the years marketing its Nexium as the ‘purple pill.’ Indian company Dr. Reddy’s Laboratories Ltd. has been blocked from selling its generic version of Nexium in the U.S. After AstraZeneca... read more